Education
BS in Chemistry - University of South Florida, Tampa, Florida, 2018
Publications
- Karim RM, Yang L, Chen L, Bikowitz MJ, Lu J, Grassie D, Shultz ZP, Lopchuk JM, Chen J, Schönbrunn E (2022). Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain. J Med Chem. [Epub ahead of print] PMID: 35191694.
- Giuliano AR, Pilon-Thomas S, Schell MJ, Abrahamsen M, Islam JY, Isaacs-Soriano K, Kennedy K, Dukes CW, Whiting J, Rathwell J, Hensel JA, Mangual LN, Schönbrunn E, Bikowitz M, Grassie D, Yang Y (2022). SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021. Emerg Infect Dis. 28:556-563 PMID: 35081021.
- Durbin AD, Wang T, Wimalasena VK, Zimmerman MW, Li D, Dharia NV, Mariani L, Shendy NAM, Nance S, Patel AG, Shao Y, Mundada M, Maxham L, Park PMC, Sigua LH, Morita K, Saur Conway A, Robichaud AL, Perez-Atayde AR, Bikowitz MJ, Quinn TR, Wiest OG, Easton J, Schönbrunn E, Bulyk ML, Abraham BJ, Stegmaier K, Look AT, Qi J (2021). EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma. Cancer Discov. 12:730-751 PMID: 34772733.
- Karim RM, Bikowitz MJ; Chan A; Zhu, JY; Grassie D; Becker A; Berndt N; Gunawan S; Lawrence NJ; Schönbrunn E (2021). Differential BET bromodomain inhibition by dihydropteridinone and pyrimidodiazepinone kinase inhibitors. J Med Chem. 64: 15772-15786 PMID: 34710325
- Muthengi A, Wimalasena VK, Yosief HO, Bikowitz MJ, Sigua LH, Wang T, Li D, Gaieb Z, Dhawan G, Liu S, Erickson J, Amaro RE, Schönbrunn E, Qi J, Zhang W (2021). Development of dimethylisoxazole-attached imidazo[1,2-α]pyridines as potent and selective CBP/P300 Inhibitors. J Med Chem. 64: 5787-5801 PMID: 33872011
E. Schönbrunn Laboratory
